The table below shows ZIMMER BIOMET HOLDINGS, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
$1.70B
$1.50B
$1.58B
-
$1.50B
$1.20B
Capital expenditure
$224.50M
$203.80M
$291.10M
$187.90M
$143.60M
$111.90M
Investing cash flow
-$1.98B
-$888.10M
-$778.90M
-
-$503.60M
-$613.80M
Dividends paid
$190.30M
$196.00M
$200.90M
$201.20M
$200.10M
ZBH operating cash flow (10-K history)
ZIMMER BIOMET HOLDINGS, INC. reported operating cash flow of $1.70B for fiscal year 2025. That is up 13.2% from $1.50B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $963.10M (FY 2013) to $1.70B. Figures come from the company's audited annual reports as filed with the SEC.
